0002158361-26-000001.txt : 20261002 0002158361-26-000001.hdr.sgml : 20261002 20261002163750 ACCESSION NUMBER: 0002158361-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261002 DATE AS OF CHANGE: 20261002 EFFECTIVENESS DATE: 20261002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Renovare Therapeutics, Inc. CENTRAL INDEX KEY: 0002158361 ORGANIZATION NAME: EIN: 421969272 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-599827 FILM NUMBER: 261437235 BUSINESS ADDRESS: STREET 1: 8871 TAHOE COURT CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 919-381-7314 MAIL ADDRESS: STREET 1: 8871 TAHOE COURT CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0708 D LIVE 0002158361 Renovare Therapeutics, Inc. 8871 TAHOE COURT BOULDER CO COLORADO 80301 919-381-7314 DELAWARE None None Corporation true 2026 Elizabeth A Scott 8870 Tahoe Court Boulder CO COLORADO 80301 Executive Officer Director Stephanie Bryant 8870 Tahoe Court Boulder CO COLORADO 80301 Director Karin Payne 8870 Tahoe Court Boulder CO COLORADO 80301 Executive Officer Biotechnology Decline to Disclose 06b false 2026-09-14 false true false 0 1000000 100000 900000 false 1 0 0 0 false Renovare Therapeutics, Inc. /s/ Elizabeth A. Scott Elizabeth A. Scott Chief Executive Officer 2026-10-02